False-positive HIV diagnoses: lessons from Ugandan and Russian research cohorts
- 2 January 2018
- journal article
- research article
- Published by Taylor & Francis in HIV Research & Clinical Practice
- Vol. 19 (1) , 15-22
Abstract
Background: Research studies rely on accurate assessment of entry criteria in order to maintain study integrity and participant safety, however, challenges can exist with HIV studies in international settings. Objective: Examine the unexpectedly high proportion of study participants with an undetectable HIV viral load found in Ugandan and Russian research cohorts meeting antiretroviral therapy (ART)-naïve entry criteria. Methods: Russian participants with documented HIV and ART-naïve status were recruited between 2012 and 2015 from clinical and non-clinical sites in St. Petersburg. Participants in Uganda were recruited from Mbarara Regional Referral Hospital from 2011 to 2014 with documented HIV infection via rapid diagnostic testing and recorded ART-naïve in the clinic database. HIV viral load testing of baseline samples was performed; the lower limit of detection was 500 copies/mL in Russia and 40 in Uganda. Due to an unexpectedly high proportion of participants with undetectable viremia, additional tests were performed: enzyme-linked immunosorbent assay HIV testing and testing for ART. Results: In Russia, 16% (58/360) had undetectable viremia; 3% (9/360) re-tested HIV-seronegative and 4% (13/360) tested positive for ART. In Uganda 11% (55/482) had undetectable viremia; 5% (26/482) re-tested HIV-seronegative, while <1% (4/482) tested positive for ART. Conclusions: In both Russia & Uganda, undetectable viremia was much higher than would be expected for an HIV-infected ART-naïve cohort. Misclassification of study participants was due to misdiagnosis of HIV with rapid diagnostic testing and inaccurate accounting of ART use. Confirmatory HIV testing could improve accuracy of participants meeting entry criteria for HIV infection as might increased scrutiny of medication use in an ART-naïve cohort.Keywords
Funding Information
- Center for AIDS Research, University of California, San Diego (P30 AI027763)
- National Institute on Alcohol Abuse and Alcoholism (U01AA020780)
- National Institute on Alcohol Abuse and Alcoholism (U24AA020778)
- National Institute on Alcohol Abuse and Alcoholism (U01AA021989)
- National Institute on Alcohol Abuse and Alcoholism (U24AA020779)
- National Institute on Alcohol Abuse and Alcoholism (U01AA020776)
- Providence/Boston Center for AIDS Research (P30AI042853)
- National Institute on Alcohol Abuse and Alcoholism (K24AA022586, U01AA020780, U24AA020779, U24AA020778, U01AA020776, U01AA021989)
- National Institute for Allergy and Infectious Diseases
- Center for AIDS Research (P30 AI027763, P30AI042853)
This publication has 25 references indexed in Scilit:
- Concealment and fabrication by experienced research subjectsClinical Trials, 2013
- False Positive HIV Diagnoses in Resource Limited Settings: Operational Lessons Learned for HIV ProgrammesPLOS ONE, 2013
- Toward an Understanding of Disengagement from HIV Treatment and Care in Sub-Saharan Africa: A Qualitative StudyPLOS Medicine, 2013
- Potential for false positive HIV test results with the serial rapid HIV testing algorithmBMC Research Notes, 2012
- Screening for acute HIV infection in South Africa: finding acute and chronic disease*HIV Medicine, 2010
- Barriers to HIV testing in Europe: a systematic reviewEuropean Journal of Public Health, 2010
- The Evaluation of a Rapid In Situ HIV Confirmation Test in a Programme with a High Failure Rate of the WHO HIV Two-Test Diagnostic AlgorithmPLOS ONE, 2009
- High HIV Prevalence, Suboptimal HIV Testing, and Low Knowledge of HIV-Positive Serostatus Among Injection Drug Users in St. Petersburg, RussiaAIDS and Behavior, 2008
- Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy studyBMJ, 2007
- Unfinished Business — Expanding HIV Testing in Developing CountriesNew England Journal of Medicine, 2006